Changes in prescribing for bipolar disorder between 2009 and 2016: national-level data linkage study in Scotland

Lyall, L. M., Penades, N. and Smith, D. J. (2019) Changes in prescribing for bipolar disorder between 2009 and 2016: national-level data linkage study in Scotland. British Journal of Psychiatry, (doi:10.1192/bjp.2019.16) (PMID:30816839) (Early Online Publication)

[img]
Preview
Text
176187.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

460kB

Abstract

Background: People with bipolar disorder typically require long-term pharmacological treatment to prevent episodes of depression or mania. However, evidence-based guidelines are often not followed by prescribers and, in some countries, prescribing of lithium is in decline. Polypharmacy is also common in bipolar disorder. Aims: To employ a data linkage approach to describe and evaluate prescribing patterns in bipolar disorder in Scotland between 2009 and 2016. Method: By linking prescribing data to the electronic Scottish Morbidity Records, we identified a cohort of 23 135 patients with bipolar disorder who were prescribed psychotropic medication between 2009 and 2016. We examined trends in proportions of patients prescribed each of six drug categories. Random effects logistic models examined change in prescribing over years of interest. Results: The most common form of treatment was antidepressant monotherapy (24.96%), with only 5.90% of patients receiving lithium monotherapy. Prescribing of antipsychotics and anti-epileptics increased from 2009 to 2016 (antipsychotics: odds ratio 1.16, 95% CI 1.15–1.18; anti-epileptics: odds ratio 1.34, 95% CI 1.32–1.36), whereas prescribing of lithium decreased (odds ratio 0.83, 95% CI 0.82–0.85). Prescribing of valproate decreased from 2009–2016 in women, but increased in men (women: odds ratio 0.93, 95% CI 0.90–0.97; men: odds ratio 1.11, 95% CI 1.04–1.18). Conclusions: Antidepressant monotherapy was the most common form of treatment for bipolar disorder in Scotland and prescribing of lithium has declined between 2009 and 2016. The findings are concerning and represent a gap between treatment guidelines and clinical practice. Declaration of interest: None.

Item Type:Articles
Status:Early Online Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Smith, Professor Daniel and Penades, Dr Nagore and Lyall, Dr Laura
Authors: Lyall, L. M., Penades, N., and Smith, D. J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Mental Health and Wellbeing
Journal Name:British Journal of Psychiatry
Publisher:Cambridge University Press
ISSN:0007-1250
ISSN (Online):1472-1465
Published Online:28 February 2019
Copyright Holders:Copyright © 2019 The Royal College of Psychiatrists
First Published:First published in British Journal of Psychiatry 2019
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
3029570Mental Health Data PathfinderDaniel SmithMedical Research Council (MRC)MC_PC_17217HW - Mental Health and Wellbeing